DualityBio Inc.
Bengbu, Anhui
What changed
Study registered, no phase assigned: Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight
1w agoTrial registeredJul 6, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 77 out of 100, unchanged since the last recompute.
Accelerating: several high-weight events landed recently.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Phase III
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Trial
Study registered
Feb 6, 2025Anesthesia, Pregnancy Related, Blockades Neuromuscular · RECRUITING · sponsor: Ohio State University · Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight
ClinicalTrials.gov · NCT07685730 (opens the source filing in a new tab)
- Trial
PHASE3 registered
Jan 29, 2024HER2-positive Breast Cancer · ACTIVE_NOT_RECRUITING · sponsor: DualityBio Inc. · A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
ClinicalTrials.gov · NCT06265428 (opens the source filing in a new tab)
- Grant
R01 · $658k · non-dilutive
Jul 5, 2023TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T · NIAID · award ends Jun 30, 2028 · Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome
NIH RePORTER · NIH RePORTER 11136933 (opens the source filing in a new tab)
- Grant
R01 · $625k · non-dilutive
May 15, 2022RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI HU, LIANGYUAN · NHLBI · award ends Apr 30, 2027 · Bayesian machine learning for causal inference with incomplete longitudinal covariates and censored survival outcomes
NIH RePORTER · NIH RePORTER 11079497 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources